A Chinese institute has applied for a national patent on a potential coronavirus treatment developed by California-based pharmaceutical giant Gilead Sciences (GILD) according to media reports. The coronavirus outbreak which originated in China's Wuhan city has led to the death of over 490 people so far. The Wuhan Institute of Virology has applied for a patent in China for the use of Remdesivir an antiviral therapy used to treat infectious diseases including Ebola and SARS TheStreet reported on Wednesday. The application was made on January 21 along with a military academy according to a statement on the institute's website. Gilead